Search for: "Bartlett v. State of California" Results 41 - 60 of 109
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2015, 11:18 am
  In any event, after Mensingand Bartlett, federal law preempts state-law claims against generic drug manufacturers for failure to warn and design defect. [read post]
31 Dec 2014, 5:00 am
  All these actions – many hundreds of plaintiffs – were filed in various California state trial courts. [read post]
7 Nov 2014, 5:52 am
Law Div. 2005).Heeding presumptions are something that exists in some states (Massachusetts, Missouri, Oklahoma), doesn’t in others (California, Connecticut, Alabama), and is limited in still others (New, Jersey, Pennsylvania, Texas). [read post]
11 Aug 2014, 11:40 am by Seyfarth Shaw LLP
  It should be noted that, after this Release went to press, the California Supreme Court addressed these issues and more in detail in Duran v. [read post]
18 Jul 2014, 11:55 am
  However, Conte was decided by but one of several California appellate courts, and we understand that they don’t have to follow each other’s decisions. [read post]
5 Mar 2014, 2:46 pm
Howmedica Osteonics Corp., California Supreme Court – state-court expert admission standards·                     Gaston v. [read post]
19 Sep 2013, 9:53 am by Bexis
  In the consultation report of the neurologist states: “Neurontin is wholly appropriate in this patient. [read post]
5 Jul 2013, 5:00 am by Bexis
Nev. 2011) (FDA compliance “relevant and admissible” but not “a bar to recovery”); Bartlett v. [read post]
2 Jul 2013, 7:32 am by Sarah Erickson-Muschko
Bartlett, holding that state-law design-defect claims which turn on the adequacy of a drug’s warnings are pre-empted by federal law. [read post]